FDA Approves New Sunscreen Ingredient After Two Decades
The FDA has approved bemotrizinol, the first new sunscreen ingredient in over 20 years, enhancing UV protection and product innovation.

The U.S. Food and Drug Administration (FDA) has approved bemotrizinol, a sunscreen filter previously used in Europe and Asia. This marks the first new sunscreen ingredient approved by the FDA in over 20 years.
This approval is expected to enhance UVA and UVB protection in U.S. sunscreen products. The ingredient is noted for its photostability and minimal skin absorption.
consumers by late 2026
Products containing bemotrizinol are anticipated to be available to U.S. consumers by late 2026. This regulatory action follows a streamlined process established by the CARES Act.
The approval aligns with strategic goals to modernize regulatory processes for over-the-counter sunscreens. This aims to improve product innovation and consumer access to advanced UV filters.
More stories
- Donor-specific genomes reveal 1,790 chromatin hotspots
- Ant genomes point to mobile DNA as size driver
- Strength-focused exercise after 50 reframes heart plans
- Flu visits double as early season puts vaccines in focus
- Hurricane Isaias halts Gulf output; US approves oil relief
- Unduliner reaches 0.897 accuracy in cancer-genome preprint
- New Research Suggests Lower Alcohol Consumption Limits for Health
- Climate Change Escalates Global Health Risks
- Americans Cut Spending for Healthcare
- Plasma Donor Deaths Prompt Health Canada Investigation
Latest news
- Bandai Namco sets 2027 cross-play test for Sparking Zero
- Washington weighs a harder bargain for Israel’s next defense aid pact
- Turkey-Israel spat puts Washington’s Gaza diplomacy in a tighter corner
- Bangladesh MICS7 shows high lead in 38.5% of children
- Mashreq CEO Abdelaal joins 15-member Swift board
- Sudan strikes kill 112, rights group says
- Ticketory says six-month bookings exceed €550,000
- Deadlock’s Solomon hides 8-to-32 chess reload boards

